Received Mar 6, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | — |
trigeminal neuralgia; fever; This non-serious case was reported by a consumer via sales rep and described the occurrence of fever in a male patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced fever (Verbatim: fever) and trigeminal neuralgia (Verbatim: trigeminal neuralgia). The outcome of the fever was resolved (duration 3 hrs) and the outcome of the trigeminal neuralgia was not reported. It was unknown if the reporter considered the fever to be related to Shingrix. The reporter considered the trigeminal neuralgia to be unlikely related to Shingrix. It was unknown if the company considered the fever to be related to Shingrix. The company considered the trigeminal neuralgia to be unlikely related to Shingrix. Additional Information: GSK Receipt Date: 27-FEB-2026 Reporter shared that he received a Shingrix shot and experienced 3 hours of fever. He also mentioned that he had a flare up of trigeminal neuralgia that the doctor thought was unrelated to Shingrix. The batch number was not provided and a request for this information has been made.